www.pharmacoreport .com is a news site providing information
about the top international pharmaceutical companies. This
website will also provide other information about these
pharmaceuticals like their address and locations, corporate
history, clinical trials, annual report, employees, careers and
jobs, health care products, research, sales, shares, dividend &
stock price, and patients’ assistance program.
Sanofi-Aventis has secured and maintained the position amongst the five biggest pharmaceuticals companies of the world that also include pharmaceutical giants like Pfizer, Bristol-Myer Squibb, Novartis and GlaxoSmithKline. The company is having it’s headquarter located in Paris, France and is engaged in consistent researching, developing, producing and commercializing of the different pharmaceutical products mainly in the prescription market segments. Moreover, the company also offers several products for sale under the OTC segments. Sanofi-Aventis including its subsidiary Sanofi-Pasteur has included 7 essential therapeutic sectors such as: cardiovascular, thrombosis, oncology, diabetes, central nervous system-CNS, internal medications and different vaccines.
The entity of Sanofi-Aventis was constituted sometimes during 2004 following Sanofi-Synthelabo duly amalgamated with Aventis when it made the aggressive takeover bid worth € 47.8 billion against Aventis. Sanofi-Synthelabo was formed in 1999 when Sanofi [which was the subsidiary of Total, earlier] amalgamated with Synthelabo [former subsidiary of L’Oreal] and this amalgamated company was located in Paris, France.
Aventis was shaped up during 1999 when Rhone-Poulenc S.A. amalgamated with Hoechst Marion Roussel which was constituted following the unification of Hoechst AG and Roussel Uclaf and Marion Merrell Dow. This new unified company was situated at Schiltigheim, near Strasbourg in France.
Sanofi-Aventis offers different medications for the treating the patients of several therapeutic sectors like: cardiovascular ailments, thrombosis related ailments, metabolic disorders, oncology diseases, central nervous system-CNS related disorders, several internal medications and different types of vaccines for preventing various diseases.
Some of the major and popular products of this company include: Lasix, Amaryl, Taxotere, Allegra, Rabipur, Frisium, Plavix, Cordarone, Stilnoct, Primacor IV, Valparin and Myoril.
By losing Aventis battle, Novartis looks like a winner
International Heroldtribüne. Herold platform international Gardiner Harris 04-28-2004 after the French drugs manufacturers agreed Aventis at the weekend, to suppose.....More
Sanofi-Aventis to license vaccine delivery technology from Becton...
PARIS (AFX) - its vaccine unit, Sanofi Pasteur has Sanofi-Aventis, said agreed to approve a vaccine delivery technology of Becton Dickinson, that that has, .....More
Sanofi-Aventis to keep US research headquarters in Malvern, Pa.
Sep. 28--Sanofi-Aventis, the worldand third largest pharmaceutical firm, becomes its USA research and drug development headquarters in Malvern retained, .....More
A Boost For France& Sanofi-Aventis
That French governmentand goal of creating a national pharmaceutical master, received a large production at the Nov. 9, when on Paris Sanofi-Aventis promises were based released. hat...More
10-Q: IMMUNOGEN INC
(EDGAR Online over COMTEX) -- THING 2nd Managementand discussion and analysis of financial condition and results of the businesses since the Companyand start, .....More
INHALABLE INSULIN GETS OK - DIABETICS GET ALTERNATIVE TO INJECTIONS
That first INHALABLE version of INSULIN federal permission won Friday, gives the million of adult DIABETIC an ALTERNATIVE to unite of the regular INJECTIONS it.....More
Regeneron Reports Third Quarter Financial and Operating Results
,) Today announced financially and operation results for the third quarter of 2006th the firm has a net loss of $27.4 million, or $0.48 per share reported.....More
BOSTON (MarketWatch) -- Bristol-Myers Squibb and Sanofi-Aventis announced late Tuesday, have that it an agreement with Apotex inc. daüber. reached....More
Sanofi-Aventis unit to double output capacity for classic flu vaccines
PARIS (AFX) - its vaccine unit, Sanofi Pasteur has Sanofi-Aventis, will double said its capacity to produce vaccine for classic flu in the next few years. .....More
THE MARKETS: STOCKS & BONDS; Dow Up 81, Hitting Highest Level in...
Through Bloomberg messages, THE Dow-Jones-industry shares index climbed yesterday to its highest plain in almost five years as THE outlook for Betriebsverdienste improved. .....More
Enquiry
Field Marked with asterisk (*) are mandatory
Name *
Email *
State/Country
Comments *
Most of the pharmaceuticals co manufacturing and r&d locations are in USA, UK, France, India, China, Australia, Canada, Ireland, Malaysia, Singapore and NJ – US. This website is for information only and not meant for any medical or health advice. Some of the information and the news might be outdated as of today.
